98.9%
of US oncologists polled for a recent survey say they have experienced
shortages of cancer drugs in the last year, and that as a result of the
shortages, cancer has progressed in more than 60% of their patients.
Over 70% of patients have experienced more severe side effects as a
result of the shortages, add the oncologists, responding to a survey conducted
by the Community Oncology Alliance (COA). Almost half of the physicians also
reported that they were seeing more than one patient per day affected by a drug
shortage, and 58.2% say the shortage of cancer drugs is increasing.
In addition, over 80% of the patients and more than 90% of the practices
affected by a cancer drug shortage experienced a more severe financial burden,
says the COA.
I do not
understand the situation: the logic should be following:
Cancer medicine
is expensive and makes huge profit for Big Pharma
→
Every medicine vial sold
gives a profit to Big Pharma
→
But the
phenomenon of shortage does exist which means that something in our scheme is
missing… What is missing? So far I do not know but I am convinced that somebody
has to get benefits (political if not direct financial and economic ones) from
this situation and I guess it should be Big Pharma. In which way? It will be
clear very soon…
No comments:
Post a Comment